Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial

Stock Information for Kane Biotech Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Kane Biotech Inc.

Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company
Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change
Kane Biotech Announces New Agreement with Outside the Box Capital Inc.
Kane Biotech Announces Canadian Distribution Agreement With Best Buy Medical for revyve(TM) Antimicrobial Wound Gel
Kane Biotech Announces Second and Final Closing of Private Placement Offering
Kane to Host Investor Webinar - What Kane has in Store for 2025 Including the Acquisition of FB Dermatology
Kane Biotech Announces First Closing of Private Placement Offering and Extension of Private Placement Offering
Kane Biotech Announces $3,000,000 Private Placement Offering

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.